
    
      Protocol for Extended Follow-up of a Phase 1 Multicenter Open Label Safety and Tolerability
      Clinical Trial of Ciliary Neurotrophic Factor (CNTF) in Patients with Macular Telangiectasia
      Type 2 (MacTel)
    
  